Number Т. 9, № 3 (35) 2019

Rubric :   Chemotherapy of solid tumors

A clinical case of treating of a patient with melanoma using checkpoint inhibitor pembolizumab (anti-PD-1 monoclonal antibody)
Author:Kosinova V.G. №4(28) 2017 / Review: 1
Antitumor therapy for patients with diabetes mellitus
Authors: Shepil A.V. Vysotsky A.G. Sivak L.A. №4(28) 2017 / Review: 969
In situ immune response after perioperative chemotherapy in patients with locally advanced breast cancer
Authors: Verevkina N.O. Sivak L.A. Lyalkin S.A. Krotevych M.S. №3(27) 2017 / Review: 1
The applying of chemotherapy in oncologic patients with functional renal lesions
Authors: Sivak L.A. Kriachok I.A. Ivanov D.D. Tarasenko T.E. №3(27) 2017 / Review: 761
Breast cancer immunotherapy: importance, prospects, problems
Authors: Sivak L.A. Verevkina N.O. №2(26) 2017 / Review: 1196
Method of improving the quality of life in patients receiving anthracycline-containing chemotherapy
Authors: Askоlskiy А.В. Sivak L.A. Shevchuk L.A. Mаydаnеvich N.N.... №2(26) 2017 / Review: 197
Influence of clinical factors of unfavorable prognosis on the results of treatment of children with malignant solid neoplasms of high-risk groups (department’s experience)
Authors: Klymniuk G.I. Izhovsky O.Y. Pavlik S.V. Shayda E.V.... №2(26) 2017 / Review: 1
The influence of allelic polymorphism of the gene CCR5 on the course of locally advanced breast cancer
Authors: Sivak L.A. Verovkina N.O. Gorovenko N.G. Lyalkin S.A.... №1(25) 2017 / Review: 1
Prevention of early anthracycline-induced cardiotoxicity in patients with breast cancer
Authors: Askоlskiy А.В. Sivak L.A. Zharinov O.I. Antomonov M.Y.... №1(25) 2017 / Review: 216
The impact of intratumoral hENT1 expression on survival in patients with pancreatic cancer treated with gemcitabine and tegafur in adjuvant setting
Authors: Dronov O.I. Zemskov S.V. Grabovyi A.N. №4(24) 2016 / Review: 663
Modern approaches to the treatment of inoperable non-small cell lung cancer
Authors: Klimаnоv М.Yu. Sivak L.A. Tarasenko T.E. Askоlskiy А.В.... №4(24) 2016 / Review: 2466
Innovative breakthrough in cancer immunotherapy: pembrolizumab opportunities
Author:Maltsev D.V. №4(24) 2016 / Review: 1
Manifestations of early anthracycline cardiotoxicity in patients with breast cancer receiving combination chemotherapy
Authors: Askоlskiy А.В. Sivak L.A. Zharinov O.I. Antomonov M.Y.... №4(24) 2016 / Review: 2
The clinical case of multiple primary cancer
Authors: Sivak L.A. Tarasenko T.E. Klimаnоv М.Yu. Lyalkin S.A.... №3(23) 2016 / Review: 1158
Prognostic and predictive value of the biological markers in locally advanced breast cancer
Authors: Sivak L.A. Verovkina N.O. Lyalkin S.A. Mаydаnеvich N.N.... №4(20) 2015 / Review: 578

123